A randomized controlled trial of zinc supplementation as adjuvant therapy for dengue viral infection in Thai children

Background: Zinc deficiency is common in developing countries and increases the risk for several infectious diseases. Low serum zinc levels have been reported in children with dengue virus infection (DVI). This study aimed to assess the effects of zinc supplementation on DVI outcomes. Methods: A dou...

Full description

Bibliographic Details
Main Authors: Sanguansak Rerksuppaphol, Lakkana Rerksuppaphol
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:International Journal of Preventive Medicine
Subjects:
Online Access:http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2018;volume=9;issue=1;spage=88;epage=88;aulast=Rerksuppaphol
id doaj-b9e7dee000f9495c9721bf73c00cdae8
record_format Article
spelling doaj-b9e7dee000f9495c9721bf73c00cdae82020-11-24T21:56:35ZengWolters Kluwer Medknow PublicationsInternational Journal of Preventive Medicine2008-78022008-82132018-01-0191888810.4103/ijpvm.IJPVM_367_17A randomized controlled trial of zinc supplementation as adjuvant therapy for dengue viral infection in Thai childrenSanguansak RerksuppapholLakkana RerksuppapholBackground: Zinc deficiency is common in developing countries and increases the risk for several infectious diseases. Low serum zinc levels have been reported in children with dengue virus infection (DVI). This study aimed to assess the effects of zinc supplementation on DVI outcomes. Methods: A double-blinded, randomized trial was conducted in 50 children with dengue fever (DF)/dengue hemorrhagic fever admitted to the pediatric unit of MSMC Srinakharinwirot University Hospital, Thailand, between January 2016 and April 2017. Bis-glycinate zinc or placebo was orally administered three times a day for 5 days or until defervescence. The primary outcome was to evaluate the DVI defervescence phase; the secondary outcome was to assess hospitalization length and presence of severe DVI and zinc deficiency. Results: The mean time of defervescence was 29.2 ± 24.0 h in the supplementation group and 38.1 ± 31.5 h in the placebo group (P = 0.270). Meantime of hospital staying was 62.5 ± 23.8 h in the supplementation group and 84.7 ± 34.0 h in placebo group with the mean difference of hospital staying between groups of 22.2 h (95% confidence interval [CI]: 5.5–38.5 h; P = 0.010). Overall prevalence of zinc deficiency was 46%. Serum zinc levels increased from baseline to the end of the study. the mean gain was 26.4 μg/dL (95% CI: 13.6–39.1 μg/dL) in the supplementation group and 14.4 μg/dL (95% CI: 7.4–21.3 μg/dL) in placebo group. No signs of severe DVI were observed in both groups. Zinc supplementation was well tolerated. Conclusions: Overcoming zinc deficiency among Thai children may reduce DF duration and limit the hospitalization, in addition to other advantages that normal serum zinc levels have on overall children health.http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2018;volume=9;issue=1;spage=88;epage=88;aulast=RerksuppapholChilddenguemicronutrientsrandomized controlled trialzinc
collection DOAJ
language English
format Article
sources DOAJ
author Sanguansak Rerksuppaphol
Lakkana Rerksuppaphol
spellingShingle Sanguansak Rerksuppaphol
Lakkana Rerksuppaphol
A randomized controlled trial of zinc supplementation as adjuvant therapy for dengue viral infection in Thai children
International Journal of Preventive Medicine
Child
dengue
micronutrients
randomized controlled trial
zinc
author_facet Sanguansak Rerksuppaphol
Lakkana Rerksuppaphol
author_sort Sanguansak Rerksuppaphol
title A randomized controlled trial of zinc supplementation as adjuvant therapy for dengue viral infection in Thai children
title_short A randomized controlled trial of zinc supplementation as adjuvant therapy for dengue viral infection in Thai children
title_full A randomized controlled trial of zinc supplementation as adjuvant therapy for dengue viral infection in Thai children
title_fullStr A randomized controlled trial of zinc supplementation as adjuvant therapy for dengue viral infection in Thai children
title_full_unstemmed A randomized controlled trial of zinc supplementation as adjuvant therapy for dengue viral infection in Thai children
title_sort randomized controlled trial of zinc supplementation as adjuvant therapy for dengue viral infection in thai children
publisher Wolters Kluwer Medknow Publications
series International Journal of Preventive Medicine
issn 2008-7802
2008-8213
publishDate 2018-01-01
description Background: Zinc deficiency is common in developing countries and increases the risk for several infectious diseases. Low serum zinc levels have been reported in children with dengue virus infection (DVI). This study aimed to assess the effects of zinc supplementation on DVI outcomes. Methods: A double-blinded, randomized trial was conducted in 50 children with dengue fever (DF)/dengue hemorrhagic fever admitted to the pediatric unit of MSMC Srinakharinwirot University Hospital, Thailand, between January 2016 and April 2017. Bis-glycinate zinc or placebo was orally administered three times a day for 5 days or until defervescence. The primary outcome was to evaluate the DVI defervescence phase; the secondary outcome was to assess hospitalization length and presence of severe DVI and zinc deficiency. Results: The mean time of defervescence was 29.2 ± 24.0 h in the supplementation group and 38.1 ± 31.5 h in the placebo group (P = 0.270). Meantime of hospital staying was 62.5 ± 23.8 h in the supplementation group and 84.7 ± 34.0 h in placebo group with the mean difference of hospital staying between groups of 22.2 h (95% confidence interval [CI]: 5.5–38.5 h; P = 0.010). Overall prevalence of zinc deficiency was 46%. Serum zinc levels increased from baseline to the end of the study. the mean gain was 26.4 μg/dL (95% CI: 13.6–39.1 μg/dL) in the supplementation group and 14.4 μg/dL (95% CI: 7.4–21.3 μg/dL) in placebo group. No signs of severe DVI were observed in both groups. Zinc supplementation was well tolerated. Conclusions: Overcoming zinc deficiency among Thai children may reduce DF duration and limit the hospitalization, in addition to other advantages that normal serum zinc levels have on overall children health.
topic Child
dengue
micronutrients
randomized controlled trial
zinc
url http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2018;volume=9;issue=1;spage=88;epage=88;aulast=Rerksuppaphol
work_keys_str_mv AT sanguansakrerksuppaphol arandomizedcontrolledtrialofzincsupplementationasadjuvanttherapyfordengueviralinfectioninthaichildren
AT lakkanarerksuppaphol arandomizedcontrolledtrialofzincsupplementationasadjuvanttherapyfordengueviralinfectioninthaichildren
AT sanguansakrerksuppaphol randomizedcontrolledtrialofzincsupplementationasadjuvanttherapyfordengueviralinfectioninthaichildren
AT lakkanarerksuppaphol randomizedcontrolledtrialofzincsupplementationasadjuvanttherapyfordengueviralinfectioninthaichildren
_version_ 1725858223067496448